Cholesterol drug tested in fight against skin condition
NCT ID NCT02432534
Summary
This study tested if adding a high-dose cholesterol medication (atorvastatin) to standard UVB light therapy could better control active vitiligo. It involved 28 adults with active, spreading vitiligo patches. Participants were randomly assigned to receive either UVB therapy alone or UVB combined with daily atorvastatin pills for six months to see which was more effective at reducing the spread and appearance of white skin patches.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU de Nice
Nice, Alpes-Maritimes, 06001, France
-
National Skin center - 1 Mandalay Rd
Bedok, Singapore, 308205, Indonesia
Conditions
Explore the condition pages connected to this study.